Applied Genetic Technologies Corporation

The Applied Genetic Technologies Corporation is a publicly traded (NASDAQ:AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has it headquarters in Alachua, Florida. The company focuses on ophthalmologic genetic diseases. The company's technologies have the ability to cure debilitating genetic diseases which include achromatopsia, X-linked retinoschisis, X-linked retinitis pigmentosa, and age-related macular degeneration. The company has six products in various stages of development.